Curing hepatitis C and vaccinating against hepatitis B could help drive down liver cancer rates in Australia. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in Australia. HCC most commonly occurs in people with liver disease: particularly in people with chronic hepatitis B and C.Read More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
AMA President, Dr Michael Gannon, said today that prevalence of BBVs is significantly higher in prisons, yet custodial facilities provide a unique opportunity to protect the health of inmates.Read More
More new medicines for hepatitis C will continue to become available in 2017 and they will be more effective across a range of hepatitis C genotypes. From 1 January [grazoprevir + elbasvir], given as a once daily tablet, will be available on the PBS and presents a new option for people with genotype 4.Read More
People living with hepatitis C and Healthcare Professionals are advised that direct-acting antiviral (DAA) medicines for the treatment of chronic hepatitis C infection have been associated with reactivation of hepatitis B virus in people with a current or previous hepatitis B infection.Read More
On 18 May 2016, the Australian Research Centre in Sex, Health and Society (ARCSHS) Blood Borne Virus Program and Cancer Council Victoria partnered with Hepatitis Australia to deliver the ‘New insights into hepatitis B: Understanding the social and cultural experiences of people affected by hepatitis B’Read More